Inhalers And Nebulizers Market: By Product Type (Jet Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer, and Others), By Modality (Portable and Table-top), By End User (Hospitals, Clinics, Homecare Settings, and Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Inhalers And Nebulizers Market was valued at USD 5,976.3 million in 2022 and is poised to grow at a CAGR of 23.2% from 2023 to 2029. A nebulizer is a machine to spray a liquid mist of medicine with a mouthpiece or mask. It is electric or battery-powered machines that turn liquid medicine into a fine mist. Inhalers are little portable devices that can fit in hand and are small enough to carry in a backpack, purse, or pocket. There are two types of inhalers Metered dose inhalers (MDI) and Dry Powder Inhalers. Metered dose inhalers (MDI) are the most commonly used inhalers like little aerosol cans. The increasing prevalence of asthma and respiratory disorders is the major driver in the global inhalers and nebulizers market growth.

According to a report in ACAAI, 8.3% of Americans have asthma which is around 26.5 million, 20.4 million are adults and 6.1 million are children and asthma prevalence is higher in children (9.4 percent) than in adults (7.7 percent), and higher in females (9.2 percent) than males (7.0 percent). Moreover, an upsurge in air pollution is another reason for increasing respiratory diseases. For instance, according to Our World in Data, air pollution is attributed to 11.65% of deaths globally and death rates from air pollution are highest in low-to-middle-income countries. Along with these, growing demand for home healthcare devices, launches of innovative smart inhalers, and increasing use of inhalers will drive the global inhalers and nebulizers market growth. The global players are influencing the market through investment, innovations, and new product launches. However, the presence of alternative treatment options may hamper the global inhalers and nebulizers market growth. 

Inhalers And Nebulizers Market Key Developments:

In July 2020, OMRON Healthcare launched of OMRON NE C106, an addition to their compressor nebulizer portfolio.

Inhalers And Nebulizers Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

23.2%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Inhalers And Nebulizers Market Dynamics

The increasing prevalence of asthma and other respiratory diseases is driving the global inhalers and nebulizers market. There has been a rise in these conditions due to various factors such as increasing consumption of cigarettes, increasing air pollution, and unhealthy lifestyles. According to the World Health Organization (WHO), asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths worldwide. The increasing prevalence of respiratory disorders is common in emerging countries such as India and Japan. Hence, it will boost global market growth.

Inhalers And Nebulizers Market Segmentation

By Product Type
  • Jet Nebulizer
  • Ultrasonic Nebulizer
  • Mesh Nebulizer
  • Others
By Modality
  • Portable
  • Table-top
By End User
  • Hospitals
  • Clinics
  • Homecare Settings
  • Others

Frequently Asked Questions

The inhalers and nebulizers market size is expected to be valued at USD 5,976.3 million in 2022.

The inhalers and nebulizers market is poised to grow at a significant CAGR of 23.2% from 2022 to 2028.

The leading players in the global inhalers and nebulizers market are Adherium Limited, Cohero Health Inc., AstraZeneca, Inc., Cognita Labs, LLC, GlaxoSmithKline Plc, Novartis AG, OPKO Health Inc., Philip Morris International Inc., Resmed Inc., Teva Pharmaceutical Industries, and Omron Healthcare.

Historic years considered for the market study are 2017 through 2021, 2021 is considered as the base year for market estimation and Seven years forecast presented from 2022 – 2028.

Key Features of the Reports

  • The inhalers and nebulizers market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Inhalers and Nebulizers Market Introduction
2.1. Global Inhalers and Nebulizers Market – Taxonomy
2.2. Global Inhalers and Nebulizers Market – Definitions
2.2.1. By Product Type
2.2.2. By Modality
2.2.3. By End User
2.2.4. By Region
3. Global Inhalers and Nebulizers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Inhalers and Nebulizers Market Dynamic Factors - Impact Analysis
3.6. Global Inhalers and Nebulizers Market – Competition Landscape
3.7. Epidemiology
4. Global Inhalers and Nebulizers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Inhalers and Nebulizers Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Jet Nebulizer
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Ultrasonic Nebulizer
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Mesh Nebulizer
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Inhalers and Nebulizers Market, By Modality, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Portable
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Table-top
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Inhalers and Nebulizers Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Clinics
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Homecare Settings
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Inhalers and Nebulizers Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Region, 2023 - 2029
9. North America Inhalers and Nebulizers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Jet Nebulizer
9.1.2. Ultrasonic Nebulizer
9.1.3. Mesh Nebulizer
9.1.4. Others
9.2. Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Portable
9.2.2. Table-top
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Homecare Settings
9.3.4. Others
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2023 - 2029
9.6. North America Inhalers and Nebulizers Market Dynamics – Trends
10. Europe Inhalers and Nebulizers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Jet Nebulizer
10.1.2. Ultrasonic Nebulizer
10.1.3. Mesh Nebulizer
10.1.4. Others
10.2. Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Portable
10.2.2. Table-top
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Homecare Settings
10.3.4. Others
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2023 - 2029
10.6. Europe Inhalers and Nebulizers Market Dynamics – Trends
11. Asia-Pacific Inhalers and Nebulizers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Jet Nebulizer
11.1.2. Ultrasonic Nebulizer
11.1.3. Mesh Nebulizer
11.1.4. Others
11.2. Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Portable
11.2.2. Table-top
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals
11.3.2. Clinics
11.3.3. Homecare Settings
11.3.4. Others
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. ASEAN
11.4.5. Australia and New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2023 - 2029
11.6. Asia-Pacific Inhalers and Nebulizers Market Dynamics – Trends
12. Latin America Inhalers and Nebulizers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Jet Nebulizer
12.1.2. Ultrasonic Nebulizer
12.1.3. Mesh Nebulizer
12.1.4. Others
12.2. Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Portable
12.2.2. Table-top
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals
12.3.2. Clinics
12.3.3. Homecare Settings
12.3.4. Others
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2023 - 2029
12.6. Latin America Inhalers and Nebulizers Market Dynamics – Trends
13. Middle East and Africa Inhalers and Nebulizers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Jet Nebulizer
13.1.2. Ultrasonic Nebulizer
13.1.3. Mesh Nebulizer
13.1.4. Others
13.2. Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Portable
13.2.2. Table-top
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals
13.3.2. Clinics
13.3.3. Homecare Settings
13.3.4. Others
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. South Africa
13.4.3. Rest of MEA
13.5. MEA Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2023 - 2029
13.6. MEA Inhalers and Nebulizers Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Key Product Types, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Adherium Limited
14.2.2. Cohero Health Inc.
14.2.3. AstraZeneca, Inc.
14.2.4. Cognita Labs, LLC
14.2.5. GlaxoSmithKline Plc
14.2.6. Novartis AG
14.2.7. OPKO Health Inc.
14.2.8. Philip Morris International Inc.
14.2.9. Resmed Inc.
14.2.10. Teva Pharmaceutical Industries
14.2.11. Omron Healthcare
15. Research Methodology
16. Key Assumptions and Acronyms
  • Adherium Limited
  • Cohero Health Inc.
  • AstraZeneca, Inc.
  • Cognita Labs, LLC
  • GlaxoSmithKline Plc
  • Novartis AG
  • OPKO Health Inc.
  • Philip Morris International Inc.
  • Resmed Inc.
  • Teva Pharmaceutical Industries
  • Omron Healthcare

Adjacent Markets